Loading
Latest filing published 29 Nov 2017 for CanniMed Therapeutics Inc., €16k.
No signal scores available.
Donald Ching discloses dealings in CanniMed Therapeutics Inc. to SEDI. Over a trading history stretching from 1 November 2016 to 28 November 2017, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 November 2017 came the latest disclosure, an option exercise for €16k in CanniMed Therapeutics Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations